Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
The move signals a major expansion in access to next-generation weight-loss therapies
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
The filing is backed by Phase III data from the lidERA Breast Cancer study
Subscribe To Our Newsletter & Stay Updated
